newsfilter
← Latest News
GlobeNewswire·

Aura Biosciences to Participate in Upcoming Investor Conferences

BOSTON, May 08, 2024 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ:AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors designed to preserve the function of the